Provided by Tiger Trade Technology Pte. Ltd.

MiMedx Group, Inc.

5.20
-0.0200-0.38%
Post-market: 5.200.00000.00%16:10 EST
Volume:816.69K
Turnover:4.23M
Market Cap:770.13M
PE:19.25
High:5.25
Open:5.17
Low:5.10
Close:5.22
52wk High:8.46
52wk Low:4.89
Shares:148.10M
Float Shares:108.77M
Volume Ratio:1.40
T/O Rate:0.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2701
EPS(LYR):0.2828
ROE:19.44%
ROA:11.98%
PB:3.22
PE(LYR):18.39

Loading ...

MiMedx Group Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
Feb 17

MiMedx price target lowered to $8 from $12 at Cantor Fitzgerald

TIPRANKS
·
Feb 17

MiMedx Group Inc. to Report Fourth Quarter and Full Year Results

Reuters
·
Feb 17

Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Omnicell (OMCL) and MiMedx Group (MDXG)

TIPRANKS
·
Feb 05

MiMedx announces distribution agreement with Summit Products Group

TIPRANKS
·
Feb 04

MiMedx Group Signs Exclusive Distribution Agreement with Summit Products Group

Reuters
·
Feb 04

MiMedx Enters Into Exclusive Distribution Agreement With Summit Products Group for Multiple Innovative Surgical & Wound Products

THOMSON REUTERS
·
Feb 04

MiMedx price target lowered to $10 from $13 at Craig-Hallum

TIPRANKS
·
Jan 23

MiMedx Group Is Maintained at Buy by Lake Street

Dow Jones
·
Jan 21

MiMedx Group (MDXG) Gets a Buy from Lake Street

TIPRANKS
·
Jan 20

MiMedx price target lowered to $10 from $12 at Lake Street

TIPRANKS
·
Jan 20

Investors Interested In MiMedx Group, Inc.'s (NASDAQ:MDXG) Earnings

Simply Wall St.
·
Jan 09

MiMedx Secures Exclusive U.S. Distribution Agreement for RegenKit-Wound Gel

Reuters
·
Dec 22, 2025

MiMedx Enters Into Exclusive U.S. Distribution Agreement for Regenkit®-Wound Gel

THOMSON REUTERS
·
Dec 22, 2025

MiMedx (MDXG): Fresh Clinical Evidence Spurs a Closer Look at the Stock’s Valuation and Long-Term Upside Potential

Simply Wall St.
·
Dec 22, 2025

How New Immunomodulation Data on Placental Allografts Will Impact MiMedx Group (MDXG) Investors

Simply Wall St.
·
Dec 20, 2025

MiMedx Publishes Study Showing Immunomodulatory Benefits of Amniotic Membrane Allografts

Reuters
·
Dec 19, 2025

Rpt-Lantheus Holdings Inc : Mizuho Raises Target Price to $72 From $60

THOMSON REUTERS
·
Dec 17, 2025

Rpt-Inspire Medical Systems Inc : Mizuho Raises Target Price to $130 From $110

THOMSON REUTERS
·
Dec 17, 2025

Rpt-Haemonetics Corp : Mizuho Raises Target Price to $90 From $75

THOMSON REUTERS
·
Dec 17, 2025